INS and type 2 diabetes mellitus: In this study, adding sitagliptin effectively reduced HbA1c by 0.9% without an increased risk of hypoglycemia or weight gain in Japanese patients with T2DM whose glycemic control was suboptimal despite at least twice daily injections of insulin.